BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kouhpayeh S, Hejazi Z, Boshtam M, Mirian M, Rahimmanesh I, Darzi L, Rezaei A, Shariati L, Khanahmad H. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis. J Cell Biochem 2019;120:16264-72. [PMID: 31111537 DOI: 10.1002/jcb.28907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Luo Z, Chen S, Zhou J, Wang C, Li K, Liu J, Tang Y, Wang L. Application of aptamers in regenerative medicine. Front Bioeng Biotechnol 2022;10:976960. [DOI: 10.3389/fbioe.2022.976960] [Reference Citation Analysis]
2 Mollasalehi N, Francois-Moutal L, Porciani D, Burke DH, Khanna M. Aptamers Targeting Hallmark Proteins of Neurodegeneration. Nucleic Acid Ther 2022. [PMID: 35452303 DOI: 10.1089/nat.2021.0091] [Reference Citation Analysis]
3 Banerjee S, Nara R, Chakraborty S, Chowdhury D, Haldar S. Integrin Regulated Autoimmune Disorders: Understanding the Role of Mechanical Force in Autoimmunity. Front Cell Dev Biol 2022;10:852878. [DOI: 10.3389/fcell.2022.852878] [Reference Citation Analysis]
4 Jamalvandi M, Khanahmad H, Irani S, Bastaminezhad S. Selection and characterization of single-stranded DNA aptamers against interleukin-5. Res Pharm Sci 2019;14:515-23. [PMID: 32038731 DOI: 10.4103/1735-5362.272560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Bing T, Zhang N, Shangguan D. Cell-SELEX, an Effective Way to the Discovery of Biomarkers and Unexpected Molecular Events. Adv Biosyst 2019;3:e1900193. [PMID: 32648677 DOI: 10.1002/adbi.201900193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]